Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aran F Labrijn

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal for Immunotherapy of Cancer|September 12, 2022
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activityOdd L Gammelgaard, Mikkel G Terp, Christian Renn, et al.
Molecular Cell|June 21, 2016
Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and AntigenGuanbo Wang, Rob N de Jong, Ewald T J van den Bremer, et al.
Frontiers in Immunology|May 22, 2020
FcγR Binding and ADCC Activity of Human IgG AllotypesSteven W de Taeye, Arthur E H Bentlage, Mirjam M Mebius, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2002
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexesMaxime Moulard, Sanjay K Phogat, Yuuei Shu, et al.
Structure (London, England : 1993)|September 7, 2011
Quantitative analysis of the interaction strength and dynamics of human IgG4 half molecules by native mass spectrometryRebecca J Rose, Aran F Labrijn, Ewald T J van den Bremer, et al.
Nature Biotechnology|July 22, 2009
Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivoAran F Labrijn, Antonio Ortiz Buijsse, Ewald T J van den Bremer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2023
The Influence of Human IgG Subclass and Allotype on Complement ActivationTimon Damelang, Steven W de Taeye, Rosa Rentenaar, et al.
Mabs|September 3, 2013
Production of stable bispecific IgG1 by controlled Fab-arm exchange: scalability from bench to large-scale manufacturing by application of standard approachesMichael J Gramer, Ewald T J van den Bremer, Muriel D van Kampen, et al.
Journal of Virology|September 13, 2003
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1Aran F Labrijn, Pascal Poignard, Aarti Raja, et al.
Ebiomedicine|January 26, 2020
DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosingPatrick J Engelberts, Ida H Hiemstra, Bart de Jong, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal for Immunotherapy of Cancer|September 12, 2022
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activityOdd L Gammelgaard, Mikkel G Terp, Christian Renn, et al.
Molecular Cell|June 21, 2016
Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and AntigenGuanbo Wang, Rob N de Jong, Ewald T J van den Bremer, et al.
Frontiers in Immunology|May 22, 2020
FcγR Binding and ADCC Activity of Human IgG AllotypesSteven W de Taeye, Arthur E H Bentlage, Mirjam M Mebius, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2002
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexesMaxime Moulard, Sanjay K Phogat, Yuuei Shu, et al.
Structure (London, England : 1993)|September 7, 2011
Quantitative analysis of the interaction strength and dynamics of human IgG4 half molecules by native mass spectrometryRebecca J Rose, Aran F Labrijn, Ewald T J van den Bremer, et al.
Nature Biotechnology|July 22, 2009
Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivoAran F Labrijn, Antonio Ortiz Buijsse, Ewald T J van den Bremer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2023
The Influence of Human IgG Subclass and Allotype on Complement ActivationTimon Damelang, Steven W de Taeye, Rosa Rentenaar, et al.
Mabs|September 3, 2013
Production of stable bispecific IgG1 by controlled Fab-arm exchange: scalability from bench to large-scale manufacturing by application of standard approachesMichael J Gramer, Ewald T J van den Bremer, Muriel D van Kampen, et al.
Journal of Virology|September 13, 2003
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1Aran F Labrijn, Pascal Poignard, Aarti Raja, et al.
Ebiomedicine|January 26, 2020
DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosingPatrick J Engelberts, Ida H Hiemstra, Bart de Jong, et al.
Pageof 4